Apogee Therapeutics, Inc. Logo

Apogee Therapeutics, Inc.

Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.

APGE | US

Overview

Corporate Details

ISIN(s):
US03770N1019
LEI:
Country:
United States of America
Address:
221 CRESCENT ST., 2453 WALTHAM
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Apogee Therapeutics, Inc. is a clinical-stage biotechnology company that develops therapies for immunological and inflammatory (I&I) diseases. The company's pipeline consists of novel antibody therapeutics and differentiated biologics designed to target established biological drivers. Apogee focuses on creating potentially best-in-class treatments for conditions with significant unmet needs, including dermatological, respiratory, and gastroenterological disorders like atopic dermatitis. Its scientific approach aims to develop medicines that offer improved efficacy and longer-lasting effects compared to the current standard of care, with the goal of improving the lives of patients with these chronic conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Apogee Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Apogee Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Apogee Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

TheraVet SA Logo
Belgium
ALVET
Theriva Biologics, Inc. Logo
Develops systemic oncolytic virus therapies to selectively destroy difficult-to-treat cancers.
United States of America
TOVX
Thor Medical ASA Logo
Sustainably produces alpha-emitters from thorium for cancer therapies, without nuclear reactors.
Norway
NANOV
Tikun Olam Cannbit Pharmaceuticals Ltd. Logo
A vertically integrated pharma company developing research-backed, EU-GMP medical cannabis products.
Israel
TKUN
Tilray Brands, Inc. Logo
A global CPG company offering cannabis, craft beverages, and wellness products in over 20 countries.
United States of America
TLRY
TITAN PHARMACEUTICALS INC Logo
Develops a long-term drug delivery implant for treating chronic central nervous system disorders.
United States of America
TTNP
TiumBio Co., Ltd. Logo
Clinical-stage biopharma developing therapies for rare diseases, gynecology, and hemophilia.
South Korea
321550
TMS Co., Ltd Logo
Develops small molecule drugs from natural compounds for the global pharmaceutical market.
Japan
4891
Together Pharma Ltd. Logo
Researches and produces medical cannabis products for domestic and European patients.
Israel
TGTR
Tonix Pharmaceuticals Holding Corp. Logo
Develops therapies and vaccines for complex conditions and public health challenges.
United States of America
TNXP

Talk to a Data Expert

Have a question? We'll get back to you promptly.